$RARX Ra Pharmaceuticals, Inc. Insider Trading Week 44/2016

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Ra Pharmaceuticals, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of insider trading in Ra Pharmaceuticals, Inc. in week 44/2016.

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Nov 02 2016	RARX	Ra Pharmaceuticals ...	Novo A/S	10% Owner	Option Exercise	C	0.00	860,438	0	0
Nov 02 2016	RARX	Ra Pharmaceuticals ...	Novo A/S	10% Owner	Option Exercise	C	0.00	924,970	0	0
Nov 02 2016	RARX	Ra Pharmaceuticals ...	Novo A/S	10% Owner	Buy	P	13.00	246,154	3,200,002	2,031,562	1.8 M to 2 M (+13.79 %)
Nov 02 2016	RARX	Ra Pharmaceuticals ...	Novo A/S	10% Owner	Buy	C	0.00	860,438	0	1,785,408	925 K to 1.8 M (+93.02 %)
Nov 02 2016	RARX	Ra Pharmaceuticals ...	Novo A/S	10% Owner	Buy	C	0.00	924,970	0	924,970	0 to 925 K
Oct 31 2016	RARX	Ra Pharmaceuticals ...	RA CAPITAL MANAGEMENT, LLC	Director	Option Exercise	C	0.00	4,015,378	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	RA CAPITAL MANAGEMENT, LLC	Director	Option Exercise	C	0.00	4,316,531	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	RA CAPITAL MANAGEMENT, LLC	Director	Buy	P	13.00	161,538	2,099,994	1,351,808	1.2 M to 1.4 M (+13.57 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	RA CAPITAL MANAGEMENT, LLC	Director	Buy	C	0.00	573,624	0	1,190,270	616.6 K to 1.2 M (+93.02 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	RA CAPITAL MANAGEMENT, LLC	Director	Buy	C	0.00	616,646	0	616,646	0 to 616.6 K
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Shah Rajeev M.	Director	Option Exercise	C	0.00	4,015,378	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Shah Rajeev M.	Director	Option Exercise	C	0.00	4,316,531	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Shah Rajeev M.	Director	Buy	P	13.00	161,538	2,099,994	1,351,808	1.2 M to 1.4 M (+13.57 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Shah Rajeev M.	Director	Buy	C	0.00	573,624	0	1,190,270	616.6 K to 1.2 M (+93.02 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Shah Rajeev M.	Director	Buy	C	0.00	616,646	0	616,646	0 to 616.6 K
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lubner David Charles	EVP & CFO	Option Exercise	A	2.87	29,285	84,048	29,285
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Weller Harry R	10% Owner	Option Exercise	C	0.00	4,362,472	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Weller Harry R	10% Owner	Option Exercise	C	0.00	4,689,657	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Weller Harry R	10% Owner	Option Exercise	C	0.00	12,447,605	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Weller Harry R	10% Owner	Option Exercise	X	0.07	80,658	5,646	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Weller Harry R	10% Owner	Buy	P	13.00	338,462	4,400,006	3,490,073	3.2 M to 3.5 M (+10.74 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Weller Harry R	10% Owner	Buy	C	0.00	623,210	0	3,151,611	2.5 M to 3.2 M (+24.65 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Weller Harry R	10% Owner	Buy	C	0.00	669,951	0	2,528,401	1.9 M to 2.5 M (+36.05 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Weller Harry R	10% Owner	Buy	C	0.00	1,778,227	0	1,858,450	80.2 K to 1.9 M (+2,216.60 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Weller Harry R	10% Owner	Sell	S	13.00	435	5,655	80,223	80.7 K to 80.2 K (-0.54 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Weller Harry R	10% Owner	Buy	X	0.07	80,658	5,646	80,658	0 to 80.7 K
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MORGENTHALER VENTURE PARTNERS ...	10% Owner	Option Exercise	C	0.00	3,408,439	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MORGENTHALER VENTURE PARTNERS ...	10% Owner	Option Exercise	C	0.00	3,664,071	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MORGENTHALER VENTURE PARTNERS ...	10% Owner	Option Exercise	C	0.00	9,744,916	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MORGENTHALER VENTURE PARTNERS ...	10% Owner	Option Exercise	X	0.07	63,019	4,411	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MORGENTHALER VENTURE PARTNERS ...	10% Owner	Buy	P	13.00	263,538	3,425,994	2,745,846	2.5 M to 2.7 M (+10.62 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MORGENTHALER VENTURE PARTNERS ...	10% Owner	Buy	C	0.00	486,919	0	2,482,308	2 M to 2.5 M (+24.40 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MORGENTHALER VENTURE PARTNERS ...	10% Owner	Buy	C	0.00	523,438	0	1,995,389	1.5 M to 2 M (+35.56 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MORGENTHALER VENTURE PARTNERS ...	10% Owner	Buy	C	0.00	1,392,130	0	1,471,951	79.8 K to 1.5 M (+1,744.06 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MORGENTHALER VENTURE PARTNERS ...	10% Owner	Sell	S	13.00	340	4,420	79,821	80.2 K to 79.8 K (-0.42 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MORGENTHALER VENTURE PARTNERS ...	10% Owner	Buy	X	0.07	63,019	4,411	80,161	17.1 K to 80.2 K (+367.63 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Viswanathan Ravi	10% Owner	Option Exercise	C	0.00	4,362,472	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Viswanathan Ravi	10% Owner	Option Exercise	C	0.00	4,689,657	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Viswanathan Ravi	10% Owner	Option Exercise	C	0.00	12,447,605	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Viswanathan Ravi	10% Owner	Option Exercise	X	0.07	80,658	5,646	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Viswanathan Ravi	10% Owner	Buy	P	13.00	338,462	4,400,006	3,490,073	3.2 M to 3.5 M (+10.74 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Viswanathan Ravi	10% Owner	Buy	C	0.00	623,210	0	3,151,611	2.5 M to 3.2 M (+24.65 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Viswanathan Ravi	10% Owner	Buy	C	0.00	669,951	0	2,528,401	1.9 M to 2.5 M (+36.05 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Viswanathan Ravi	10% Owner	Buy	C	0.00	1,778,227	0	1,858,450	80.2 K to 1.9 M (+2,216.60 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Viswanathan Ravi	10% Owner	Sell	S	13.00	435	5,655	80,223	80.7 K to 80.2 K (-0.54 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Viswanathan Ravi	10% Owner	Buy	X	0.07	80,658	5,646	80,658	0 to 80.7 K
Oct 31 2016	RARX	Ra Pharmaceuticals ...	SANDELL SCOTT D	10% Owner	Option Exercise	C	0.00	4,362,472	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	SANDELL SCOTT D	10% Owner	Option Exercise	C	0.00	4,689,657	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	SANDELL SCOTT D	10% Owner	Option Exercise	C	0.00	12,447,605	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	SANDELL SCOTT D	10% Owner	Option Exercise	X	0.07	80,658	5,646	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	SANDELL SCOTT D	10% Owner	Buy	P	13.00	338,462	4,400,006	3,490,073	3.2 M to 3.5 M (+10.74 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	SANDELL SCOTT D	10% Owner	Buy	C	0.00	623,210	0	3,151,611	2.5 M to 3.2 M (+24.65 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	SANDELL SCOTT D	10% Owner	Buy	C	0.00	669,951	0	2,528,401	1.9 M to 2.5 M (+36.05 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	SANDELL SCOTT D	10% Owner	Buy	C	0.00	1,778,227	0	1,858,450	80.2 K to 1.9 M (+2,216.60 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	SANDELL SCOTT D	10% Owner	Sell	S	13.00	435	5,655	80,223	80.7 K to 80.2 K (-0.54 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	SANDELL SCOTT D	10% Owner	Buy	X	0.07	80,658	5,646	80,658	0 to 80.7 K
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	C	0.00	481,503	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	C	0.00	3,533,875	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	C	0.00	517,617	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	C	0.00	3,798,914	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	C	0.00	3,408,439	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	C	0.00	3,664,071	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	C	0.00	9,744,916	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	X	0.07	63,019	4,411	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	P	13.00	15,633	203,229	4,066,503	4.1 M to 4.1 M (+0.39 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	P	13.00	114,752	1,491,776	4,050,870	3.9 M to 4.1 M (+2.92 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	P	13.00	263,538	3,425,994	3,936,118	3.7 M to 3.9 M (+7.18 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	C	0.00	68,786	0	3,672,580	3.6 M to 3.7 M (+1.91 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	C	0.00	504,839	0	3,603,794	3.1 M to 3.6 M (+16.29 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	C	0.00	73,945	0	3,098,955	3 M to 3.1 M (+2.44 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	C	0.00	542,702	0	3,025,010	2.5 M to 3 M (+21.86 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	C	0.00	486,919	0	2,482,308	2 M to 2.5 M (+24.40 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	C	0.00	523,438	0	1,995,389	1.5 M to 2 M (+35.56 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	C	0.00	1,392,130	0	1,471,951	79.8 K to 1.5 M (+1,744.06 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Sell	S	13.00	340	4,420	79,821	80.2 K to 79.8 K (-0.42 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	X	0.07	63,019	4,411	80,161	17.1 K to 80.2 K (+367.63 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	4,362,472	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	4,689,657	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MOTT DAVID M	10% Owner	Option Exercise	C	0.00	12,447,605	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MOTT DAVID M	10% Owner	Option Exercise	X	0.07	80,658	5,646	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MOTT DAVID M	10% Owner	Buy	P	13.00	338,462	4,400,006	3,490,073	3.2 M to 3.5 M (+10.74 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MOTT DAVID M	10% Owner	Buy	C	0.00	623,210	0	3,151,611	2.5 M to 3.2 M (+24.65 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MOTT DAVID M	10% Owner	Buy	C	0.00	669,951	0	2,528,401	1.9 M to 2.5 M (+36.05 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MOTT DAVID M	10% Owner	Buy	C	0.00	1,778,227	0	1,858,450	80.2 K to 1.9 M (+2,216.60 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MOTT DAVID M	10% Owner	Sell	S	13.00	435	5,655	80,223	80.7 K to 80.2 K (-0.54 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MOTT DAVID M	10% Owner	Buy	X	0.07	80,658	5,646	80,658	0 to 80.7 K
Oct 31 2016	RARX	Ra Pharmaceuticals ...	KOLLURI KRISHNA KITTU	10% Owner	Option Exercise	C	0.00	4,362,472	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	KOLLURI KRISHNA KITTU	10% Owner	Option Exercise	C	0.00	4,689,657	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	KOLLURI KRISHNA KITTU	10% Owner	Option Exercise	C	0.00	12,447,605	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	KOLLURI KRISHNA KITTU	10% Owner	Option Exercise	X	0.07	80,658	5,646	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	KOLLURI KRISHNA KITTU	10% Owner	Buy	P	13.00	338,462	4,400,006	3,490,073	3.2 M to 3.5 M (+10.74 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	KOLLURI KRISHNA KITTU	10% Owner	Buy	C	0.00	623,210	0	3,151,611	2.5 M to 3.2 M (+24.65 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	KOLLURI KRISHNA KITTU	10% Owner	Buy	C	0.00	669,951	0	2,528,401	1.9 M to 2.5 M (+36.05 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	KOLLURI KRISHNA KITTU	10% Owner	Buy	C	0.00	1,778,227	0	1,858,450	80.2 K to 1.9 M (+2,216.60 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	KOLLURI KRISHNA KITTU	10% Owner	Sell	S	13.00	435	5,655	80,223	80.7 K to 80.2 K (-0.54 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	KOLLURI KRISHNA KITTU	10% Owner	Buy	X	0.07	80,658	5,646	80,658	0 to 80.7 K
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Option Exercise	C	0.00	3,402,729	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Option Exercise	C	0.00	3,657,932	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Option Exercise	C	0.00	9,728,589	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Option Exercise	X	0.07	62,914	4,404	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Buy	P	13.00	84,615	1,099,995	2,545,652	2.5 M to 2.5 M (+3.44 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Buy	C	0.00	486,104	0	2,461,037	2 M to 2.5 M (+24.61 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Buy	C	0.00	522,561	0	1,974,933	1.5 M to 2 M (+35.98 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Buy	C	0.00	1,389,797	0	1,452,372	62.6 K to 1.5 M (+2,221.01 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	13.00	339	4,407	62,575	62.9 K to 62.6 K (-0.54 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Buy	X	0.07	62,914	4,404	62,914	0 to 62.9 K
Oct 31 2016	RARX	Ra Pharmaceuticals ...	KERINS PATRICK J	10% Owner	Option Exercise	C	0.00	4,362,472	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	KERINS PATRICK J	10% Owner	Option Exercise	C	0.00	4,689,657	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	KERINS PATRICK J	10% Owner	Option Exercise	C	0.00	12,447,605	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	KERINS PATRICK J	10% Owner	Option Exercise	X	0.07	80,658	5,646	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	KERINS PATRICK J	10% Owner	Buy	P	13.00	338,462	4,400,006	3,490,073	3.2 M to 3.5 M (+10.74 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	KERINS PATRICK J	10% Owner	Buy	C	0.00	623,210	0	3,151,611	2.5 M to 3.2 M (+24.65 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	KERINS PATRICK J	10% Owner	Buy	C	0.00	669,951	0	2,528,401	1.9 M to 2.5 M (+36.05 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	KERINS PATRICK J	10% Owner	Buy	C	0.00	1,778,227	0	1,858,450	80.2 K to 1.9 M (+2,216.60 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	KERINS PATRICK J	10% Owner	Sell	S	13.00	435	5,655	80,223	80.7 K to 80.2 K (-0.54 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	KERINS PATRICK J	10% Owner	Buy	X	0.07	80,658	5,646	80,658	0 to 80.7 K
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BASKETT FOREST	10% Owner	Option Exercise	C	0.00	4,362,472	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BASKETT FOREST	10% Owner	Option Exercise	C	0.00	4,689,657	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BASKETT FOREST	10% Owner	Option Exercise	C	0.00	12,447,605	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BASKETT FOREST	10% Owner	Option Exercise	X	0.07	80,658	5,646	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BASKETT FOREST	10% Owner	Buy	P	13.00	338,462	4,400,006	3,490,073	3.2 M to 3.5 M (+10.74 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BASKETT FOREST	10% Owner	Buy	C	0.00	623,210	0	3,151,611	2.5 M to 3.2 M (+24.65 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BASKETT FOREST	10% Owner	Buy	C	0.00	669,951	0	2,528,401	1.9 M to 2.5 M (+36.05 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BASKETT FOREST	10% Owner	Buy	C	0.00	1,778,227	0	1,858,450	80.2 K to 1.9 M (+2,216.60 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BASKETT FOREST	10% Owner	Sell	S	13.00	435	5,655	80,223	80.7 K to 80.2 K (-0.54 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BASKETT FOREST	10% Owner	Buy	X	0.07	80,658	5,646	80,658	0 to 80.7 K
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BARRIS PETER J	10% Owner	Option Exercise	C	0.00	4,362,472	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BARRIS PETER J	10% Owner	Option Exercise	C	0.00	4,689,657	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BARRIS PETER J	10% Owner	Option Exercise	C	0.00	12,447,605	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BARRIS PETER J	10% Owner	Option Exercise	X	0.07	80,658	5,646	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BARRIS PETER J	10% Owner	Buy	P	13.00	338,462	4,400,006	3,490,073	3.2 M to 3.5 M (+10.74 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BARRIS PETER J	10% Owner	Buy	C	0.00	623,210	0	3,151,611	2.5 M to 3.2 M (+24.65 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BARRIS PETER J	10% Owner	Buy	C	0.00	669,951	0	2,528,401	1.9 M to 2.5 M (+36.05 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BARRIS PETER J	10% Owner	Buy	C	0.00	1,778,227	0	1,858,450	80.2 K to 1.9 M (+2,216.60 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BARRIS PETER J	10% Owner	Sell	S	13.00	435	5,655	80,223	80.7 K to 80.2 K (-0.54 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BARRIS PETER J	10% Owner	Buy	X	0.07	80,658	5,646	80,658	0 to 80.7 K
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BARRETT M JAMES	10% Owner	Option Exercise	C	0.00	4,362,472	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BARRETT M JAMES	10% Owner	Option Exercise	C	0.00	4,689,657	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BARRETT M JAMES	10% Owner	Option Exercise	C	0.00	12,447,605	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BARRETT M JAMES	10% Owner	Option Exercise	X	0.07	80,658	5,646	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BARRETT M JAMES	10% Owner	Buy	P	13.00	338,462	4,400,006	3,490,073	3.2 M to 3.5 M (+10.74 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BARRETT M JAMES	10% Owner	Buy	C	0.00	623,210	0	3,151,611	2.5 M to 3.2 M (+24.65 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BARRETT M JAMES	10% Owner	Buy	C	0.00	669,951	0	2,528,401	1.9 M to 2.5 M (+36.05 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BARRETT M JAMES	10% Owner	Buy	C	0.00	1,778,227	0	1,858,450	80.2 K to 1.9 M (+2,216.60 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BARRETT M JAMES	10% Owner	Sell	S	13.00	435	5,655	80,223	80.7 K to 80.2 K (-0.54 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	BARRETT M JAMES	10% Owner	Buy	X	0.07	80,658	5,646	80,658	0 to 80.7 K
Oct 31 2016	RARX	Ra Pharmaceuticals ...	NEW ENTERPRISE ASSOCIATES 13 L ...	10% Owner	Option Exercise	C	0.00	4,362,472	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	NEW ENTERPRISE ASSOCIATES 13 L ...	10% Owner	Option Exercise	C	0.00	4,689,657	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	NEW ENTERPRISE ASSOCIATES 13 L ...	10% Owner	Option Exercise	C	0.00	12,447,605	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	NEW ENTERPRISE ASSOCIATES 13 L ...	10% Owner	Option Exercise	X	0.07	80,658	5,646	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	NEW ENTERPRISE ASSOCIATES 13 L ...	10% Owner	Buy	P	13.00	338,462	4,400,006	3,490,073	3.2 M to 3.5 M (+10.74 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	NEW ENTERPRISE ASSOCIATES 13 L ...	10% Owner	Buy	C	0.00	623,210	0	3,151,611	2.5 M to 3.2 M (+24.65 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	NEW ENTERPRISE ASSOCIATES 13 L ...	10% Owner	Buy	C	0.00	669,951	0	2,528,401	1.9 M to 2.5 M (+36.05 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	NEW ENTERPRISE ASSOCIATES 13 L ...	10% Owner	Buy	C	0.00	1,778,227	0	1,858,450	80.2 K to 1.9 M (+2,216.60 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	NEW ENTERPRISE ASSOCIATES 13 L ...	10% Owner	Sell	S	13.00	435	5,655	80,223	80.7 K to 80.2 K (-0.54 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	NEW ENTERPRISE ASSOCIATES 13 L ...	10% Owner	Buy	X	0.07	80,658	5,646	80,658	0 to 80.7 K